RASSF6 and nasopharyngeal carcinoma: To assess whether RASSF6 alters the sensitivity of NPC cells toward cisplatin or radiation treatment and to determine the general role of RASSF6 in NPC cells, we compared another highly metastatic NPC cell line, 5-8F, to its parental, low metastatic cell line SUNE-1.